626 filings
ARS
2023 FY
PVCT
Provectus Biopharmaceuticals, Inc.
9 May 24
Annual report to shareholders
10:54am
DEFA14A
PVCT
Provectus Biopharmaceuticals, Inc.
6 May 24
Additional proxy soliciting materials
1:57pm
DEF 14A
PVCT
Provectus Biopharmaceuticals, Inc.
Definitive proxy
6 May 24
1:56pm
PRE 14A
PVCT
Provectus Biopharmaceuticals, Inc.
Preliminary proxy
26 Apr 24
11:48am
8-K
moj qk3b8
16 Apr 24
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
4:58pm
8-K
eaggp
27 Mar 24
Entry into a Material Definitive Agreement
12:10pm
8-K
8e71z h8ddbpnf0
26 Mar 24
Departure of Directors or Certain Officers
4:48pm
8-K
unucvf j0c
22 Feb 24
Regulation FD Disclosure
9:30am
8-K
7br2bq5x
15 Feb 24
Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
8:05am
8-K
2eqmn1cqpk7wsep8kp
22 Jun 23
Submission of Matters to a Vote of Security Holders
12:00am
8-K
69kh7egpte6 xnwogx
21 Jun 23
Regulation FD Disclosure
9:50am
DEFA14A
pzvgaonyzl5bp8fmc2i
21 Jun 23
Additional proxy soliciting materials
9:45am
ARS
ouehnpal3eccz4g
11 May 23
Annual report to shareholders
3:18pm
DEFA14A
9msfm09ruxya5p7oc
1 May 23
Additional proxy soliciting materials
2:01pm